GT Biopharma Inc Up 20.52% To $0.56 After Earnings Miss

by InvestorsObserver, Benzinga Columnist
March 31, 2023 2:51 PM | 17 seconds read |
GT Biopharma Inc (GTBP) missed earnings projections on 3/30/2023 for Q4 2022.Analyst expectations for GT Biopharma Inc earnings per share (EPS) were at a loss of $0.17 per share, with the company missing those estimates with a reported EPS loss of $0.18 per share, leading to a negative surprise of $0.01 per share (-6%). GT
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!